hotspot -WSS

hotspot

author：comprehensive 2025-09-27 09:45:27 - browse：33215

A medical device to treat below-the-knee chronic limb-threatening ischemia, Esprit BTK resorbable scaffold, is shown consisted of pieces of geometric shapes that lined up into a pipe on a blue background — health tech coverage from STAT — Cardiovascular doctors are optimistic about Abbott’s new below-knee stent that disappears into the blood vessel’s walls over the course of three years. Courtesy Abbott

An Abbott device that failed in heart disease patients is getting a new life in patients with severe vascular disease.

The device is a below-knee stent that widens clogged blood vessels, and then vanishes into the vessel’s walls over the course of three years. It also delivers a drug that prevents scar tissue from forming — a common risk factor with traditional metal stents that further narrow the vessel.

Abbott’s first dissolvable stent, for coronary artery disease, received Food and Drug Administration approval in 2016. But the company voluntarily pulled the product from the market just over a year later due to “low commercial uptake.” The device also received mixed results in clinical trials.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Listen: Biogen's messy board & Laronde's data problem

knowledge

leisure time

WSS

4 killed, 7 hurt in mass shooting at July 4 block party in Louisiana; no arrests made

White House drug shortage group privately met with industry

Doctor appointment wait times are getting worse

Gilgo Beach: Police identify another victim in serial killing investigation

Verily hires former Apple Health leader as chief scientific officer

Influencer to be charged after chaos erupts in New York City's Union Square

knowledge

hotspot

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

hotspot

Drug repurposing or repositioning? The language matters

Community addresses injustice for Long Island mothers

The high cost of giving birth even with insurance

Attacks on the drug industry will lead to fewer breakthroughs

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Listen: Biogen's messy board & Laronde's data problem

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

What the cancer research community can learn from the Covid response

Supreme Court strikes down use of affirmative action

A new study asks: Are we harming blood donors by taking blood?

Wikipedia

The drug industry sees a key ally in the Senate prevail

Influencer to be charged after chaos erupts in New York City's Union Square

Humana, CVS hope to turn members into patients at clinics

Grail is spending more than ever lobbying Congress

Influencer to be charged after chaos erupts in New York City's Union Square

Mega Millions jackpot rises to record $1.55 billion for Tuesday's drawing

knowledge

leisure time

focus

explore